Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Transl Behav Med. 2023 Aug 11;13(8):539-550. doi: 10.1093/tbm/ibac122.
Tobacco use among cancer patients is associated with an increased mortality and poorer outcomes, yet two-thirds of patients continue using following diagnosis, with disproportionately higher use among racial/ethnic minority and low socioeconomic status patients. Tobacco treatment services that are effectively tailored and adapted to population characteristics and multilevel context specific to settings serving diverse patients are needed to improve tobacco cessation among cancer patients. We examined tobacco use screening and implementation needs for tobacco treatment services to inform equitable and accessible delivery within a large comprehensive cancer center in the greater Los Angeles region. We conducted a multi-modal, mixed methods assessment using electronic medical records (EMR), and clinic stakeholder surveys and interviews (guided by the Consolidated Framework for Implementation Research). Approximately 45% of patients (n = 11,827 of 26,030 total) had missing tobacco use history in their EMR. Several demographic characteristics (gender, age, race/ethnicity, insurance) were associated with greater missing data prevalence. In surveys (n = 32), clinic stakeholders endorsed tobacco screening and cessation services, but indicated necessary improvements for screening/referral procedures. During interviews (n = 13), providers/staff reported tobacco screening was important, but level of priority differed as well as how often and who should screen. Several barriers were noted, including patients' language/cultural barriers, limited time during visits, lack of smoking cessation training, and insurance coverage. While stakeholders indicated high interest in tobacco use assessment and cessation services, EMR and interview data revealed opportunities to improve tobacco use screening across patient groups. Implementing sustainable system-level tobacco cessation programs at institutions requires leadership support, staff training, on routine screening, and intervention and referral strategies that meet patients' linguistic/cultural needs.
癌症患者的吸烟行为与死亡率增加和预后不良有关,但三分之二的患者在确诊后仍继续吸烟,且在少数族裔和低社会经济地位患者中比例更高。需要为癌症患者提供量身定制和适应人口特征以及针对服务多样化患者的多层次环境的烟草治疗服务,以提高戒烟率。我们研究了烟草使用筛查和实施烟草治疗服务的需求,以便在洛杉矶大都市区的一家大型综合癌症中心内提供公平和可及的服务。我们采用电子病历(EMR)和临床利益相关者调查和访谈(以实施研究综合框架为指导)进行了多模式、混合方法评估。约有 45%的患者(n=11827/26030 总)在 EMR 中缺少吸烟史记录。一些人口统计学特征(性别、年龄、种族/族裔、保险)与更大的缺失数据流行率相关。在调查(n=32)中,临床利益相关者支持烟草筛查和戒烟服务,但表示筛查/转介程序需要改进。在访谈(n=13)中,医生/工作人员表示烟草筛查很重要,但筛查的优先级、频率和应由谁进行筛查存在差异。还注意到了一些障碍,包括患者的语言/文化障碍、就诊时间有限、缺乏戒烟培训以及保险覆盖范围。尽管利益相关者表示对烟草使用评估和戒烟服务有浓厚兴趣,但 EMR 和访谈数据揭示了需要改进所有患者群体的烟草使用筛查的机会。在机构中实施可持续的系统层面的戒烟计划需要领导层的支持、员工培训、常规筛查以及满足患者语言/文化需求的干预和转介策略。